PROMACTA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Eltrombopag Ola.
| Product ID | 0007-4642_c7c46a73-1f77-45f6-ab60-1aa8f9e87463 |
| NDC | 0007-4642 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PROMACTA |
| Generic Name | Eltrombopag Olamine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-01-05 |
| Marketing End Date | 2019-03-31 |
| Marketing Category | NDA / |
| Application Number | NDA022291 |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ELTROMBOPAG OLA |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Increased Megak |
| NDC Exclude Flag | N |
| Marketing Category | NDA |
| Application Number | NDA022291 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-01-05 |
| Marketing End Date | 2019-03-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0007-4640 | PROMACTA | eltrombopag olamine |
| 0007-4641 | PROMACTA | eltrombopag olamine |
| 0007-4642 | PROMACTA | eltrombopag olamine |
| 0007-4643 | PROMACTA | eltrombopag olamine |
| 0078-0684 | PROMACTA | eltrombopag olamine |
| 0078-0685 | PROMACTA | eltrombopag olamine |
| 0078-0686 | PROMACTA | eltrombopag olamine |
| 0078-0687 | PROMACTA | eltrombopag olamine |
| 0078-0697 | PROMACTA | eltrombopag olamine |
| 0078-0972 | PROMACTA | PROMACTA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PROMACTA 85969206 4475188 Live/Registered |
GlaxoSmithKline LLC 2013-06-25 |
![]() PROMACTA 85917561 not registered Dead/Abandoned |
GlaxoSmithKline LLC 2013-04-29 |
![]() PROMACTA 78890371 3334886 Live/Registered |
NOVARTIS PHARMA AG 2006-05-23 |
![]() PROMACTA 78616041 3499088 Live/Registered |
NOVARTIS PHARMA AG 2005-04-25 |
![]() PROMACTA 77616496 not registered Dead/Abandoned |
GLAXOSMITHKLINE LLC 2008-11-18 |
![]() PROMACTA 75272520 2358999 Dead/Cancelled |
GLAXO GROUP LIMITED 1997-04-10 |